Derek Meisner
2023 - Acumen Pharmaceuticals
In 2023, Derek Meisner earned a total compensation of $1.5M as Chief Legal Officer at Acumen Pharmaceuticals, a 15% increase compared to previous year.
Compensation breakdown
| Bonus | $45,000 |
|---|---|
| Non-Equity Incentive Plan | $236,945 |
| Option Awards | $559,944 |
| Salary | $455,663 |
| Stock Awards | $163,748 |
| Other | $15,337 |
| Total | $1,476,637 |
Meisner received $559.9K in option awards, accounting for 38% of the total pay in 2023.
Meisner also received $45K in bonus, $236.9K in non-equity incentive plan, $455.7K in salary, $163.7K in stock awards and $15.3K in other compensation.
Rankings
In 2023, Derek Meisner's compensation ranked 808th out of 3,006 executives tracked by ExecPay. In other words, Meisner earned more than 73.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 808 out of 3,006 | 73rd |
Division Manufacturing | 473 out of 1,650 | 71st |
Major group Chemicals And Allied Products | 323 out of 918 | 65th |
Industry group Drugs | 315 out of 881 | 64th |
Industry Biological Products, Except Diagnostic Substances | 101 out of 213 | 53rd |
Source: SEC filing on April 22, 2024.
Meisner's colleagues
We found two more compensation records of executives who worked with Derek Meisner at Acumen Pharmaceuticals in 2023.
News
Acumen Pharmaceuticals CEO Daniel O'Connell's 2023 pay jumps 48% to $3.9M
April 22, 2024
Acumen Pharmaceuticals CEO Daniel O'Connell's 2022 pay jumps 80% to $2.7M
April 27, 2023
X4 Pharmaceuticals CEO Paula Ragan's 2021 pay slips 15% to $2.1M
April 25, 2022
X4 Pharmaceuticals CEO Paula Ragan's 2020 pay rises 1% to $2.5M
April 20, 2021